Peginterferon beta-1a in relapsing–remitting multiple sclerosis: a guide to its use in the EU

Authors
Category Primary study
JournalDrugs and Therapy Perspectives
Year 2015
This article has no abstract
Epistemonikos ID: 5c7a9b3022de8358fe171ade3458cb496a268f2d
First added on: Mar 31, 2022